share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Klinger Shannon Thyme

Moderna | 4:持股變動聲明-高管 Klinger Shannon Thyme

SEC announcement ·  03/02 06:30
牛牛AI助理已提取核心訊息
Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a sale of 670 shares of common stock on 02/29/2024, as per the latest SEC filings. The transaction was executed at a price of $94.572 per share, resulting in a total sale value of $63,363.24. Prior to this sale, Klinger acquired 1,315 shares through the exercise of derivative securities on 02/28/2024. Following these transactions, Klinger's direct holdings in Moderna amount to 8,557 shares of common stock.
Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a sale of 670 shares of common stock on 02/29/2024, as per the latest SEC filings. The transaction was executed at a price of $94.572 per share, resulting in a total sale value of $63,363.24. Prior to this sale, Klinger acquired 1,315 shares through the exercise of derivative securities on 02/28/2024. Following these transactions, Klinger's direct holdings in Moderna amount to 8,557 shares of common stock.
Moderna, Inc. '根據美國證券交易委員會的最新文件,首席法務官香農·泰裏姆·克林格於2024年2月29日完成了670股普通股的出售。該交易以每股94.572美元的價格執行,總銷售價值爲63,363.24美元。在此次出售之前,克林格於2024年2月28日通過行使衍生證券收購了1,315股股票。這些交易之後,克林格在Moderna的直接持有量爲8,557股普通股。
Moderna, Inc. '根據美國證券交易委員會的最新文件,首席法務官香農·泰裏姆·克林格於2024年2月29日完成了670股普通股的出售。該交易以每股94.572美元的價格執行,總銷售價值爲63,363.24美元。在此次出售之前,克林格於2024年2月28日通過行使衍生證券收購了1,315股股票。這些交易之後,克林格在Moderna的直接持有量爲8,557股普通股。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。